Newsletter Subject

3 "Mpox Stocks" to Buy Right Now

From

behindthemarkets.com

Email Address

newsletter@lg.behindthemarkets.com

Sent On

Tue, Sep 3, 2024 01:05 PM

Email Preheader Text

The WHO's health emergency could be a boon for these stocks here. Prefer to view this content

The WHO's health emergency could be a boon for these stocks [Morning Watchlist] You are receiving this email because you are subscribed to Behind the Markets. If you no longer wish to receive these emails, please [unsubscribe]( here.  Prefer to view this content on our website? [Click here.]( --------------------------------------------------------------- Dear Fellow Investor, The World Health Organization (WHO) just declared Mpox a global public health emergency for the second time following an outbreak in the Democratic Republic of Congo to other countries. As noted by CNBC, “Health officials are raising concerns because many of the new cases in Africa have been identified as a new and deadlier strain, known as clade 1b. The new strain has also been confirmed outside of the continent, in Thailand.” --------------------------------------------------------------- That being said, investors may want to jump into Mpox testing and treatment stocks, such as: Company: Virax Biolabs (SYM: VRAX) VRAX just signed a distribution pact for Mpox diagnostic kits in Europe and the Middle East. “The RT PCR Mpox virus detection kits are approved for sale in Europe and also authorized by the Medicines and Healthcare Products Regulatory Agency, the product regulatory agency for the United Kingdom. These tests perform with a sensitivity of 96.7% and specificity of 93.72%, with the ability to deliver results in under 70 minutes,” as noted by Benzinga. --------------------------------------------------------------- Crypto 101 [How to Turn $3 into Generational Wealth]( [bitcoin guy](The biggest gains in crypto come from being early and right. For a limited time, get expert info on the coin poised to soar as real-world assets flood onto the blockchain. It's your chance to invest alongside the financial elite with just $3. [Discover the “$3 Secret” to this new crypto]( --------------------------------------------------------------- Company: Emergent BioSolutions (SYM: EBS) EBS is also pushing higher on the Mpox story. Since bottoming out at around $5.25, it’s now up to $9.28 and could test higher highs if the outbreak gets worse. “Emergent BioSolutions' ACAM2000 vaccine, approved for smallpox, is currently under FDA review as a mode of immunization against the mpox virus. The company has also responded to the WHO's request for information for a potential emergency listing,” noted Seeking Alpha. --------------------------------------------------------------- Trading Tips [Top 5 Stocks to Buy Ahead of the Presidential Election in 2024]( Things are heating up in politics as we approach the Election, and it could mean big wins for your wallet. If Trump wins in 2024, some companies will do really well. Our friends at Trading Tips have found 5 of these companies and put them in a free report for you: "5 Stocks to Buy if Trump is Elected President in 2024." [Click here to claim your free copy of this report.]( (By clicking this link you agree to receive emails from Trading Tips and their affiliates. You can opt out at any time.) --------------------------------------------------------------- Company: Applied DNA Sciences (SYM: APDN) APDN just announced that its clinical laboratory subsidiary, Applied DNA Clinical Labs, submitted a validation package to the New York State Department of Health in support of an expansion of the permitted use of its Linea Mpox Virus 1.0 Assay to include both mpox clade I and clade II, as noted in a company press release. --------------------------------------------------------------- Weiss Ratings [Nvidia Ex-Partners Soared up to 4,744%: $1T AI Pivot Lures New Names](Nvidia's past collaborations have often benefitted both parties, with one rising as much as 4,744%. As Nvidia pivots to capitalize on a new $1 trillion opportunity in AI, fresh alliances are forming. Dr. Martin Weiss has pinpointed three silent partners that could play a crucial role in this phase of the AI boom. [Watch urgently: Dr. Weiss unveils Nvidia's new partners in its game-changing $1T AI pivot!]( --------------------------------------------------------------- [Join Daily Guru Trades!]( Want more free daily trades in your inbox? [Sign up for Dylan Jovine's Daily Guru Trades Today.]( Do you curently own shares of healthcare/biotech stocks? Do you have your eye on any other under-the-radar healthcare or biotech stocks we might have missed? Hit "reply" to this email and let us know! Our mailing address is: Behind the Markets, LLC 4260 NW 1st Avenue, Suite 55 Boca Raton, FL 33431 Copyright © 2024 Behind the Markets, LLC, All rights reserved. You're receiving this email as part of your subscription to Behind the Markets. For more information about our privacy practices, please review our [Privacy Policy]( or our [Legal Notices.]( [Behind the Markets](  [Unsubscribe]( Â

Marketing emails from behindthemarkets.com

View More
Sent On

08/12/2024

Sent On

07/12/2024

Sent On

07/12/2024

Sent On

07/12/2024

Sent On

06/12/2024

Sent On

06/12/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.